Search

everythinglearnresearchcommunity

for

Search:↓

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Metformin reduces pregnancy complications in women with PCOS.

Low-dose flutamide-metformin therapy effectively improved PCOS symptoms in adolescent girls.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

DHT, not testosterone, mainly affects hair growth and related conditions.

Evaluate prolactin levels with androgen and thyroid tests to rule out endocrine issues in patients with SAHA syndrome symptoms.

Drugs can change hair growth and this is important because it can upset people.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Higher levels of 3α-diol G are linked to more severe female pattern hair loss.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

New treatments for androgenetic alopecia show promise but need more research for validation.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

Hirsutism, often caused by PCOS, is treated with medication and weight loss is important for obese women with PCOS.

No link between hair loss and blood groups or Rhesus factor.

Dermal papilla cells play a key role in hair loss by responding to androgens.

High prolactin levels can cause skin and hair symptoms similar to those caused by hormone imbalances.

High levels of androgens during early development may cause PCOS-like symptoms.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Testosterone may influence COVID-19 severity and outcomes.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.